These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2551305)

  • 1. Effects of lidocaine alone and in combination with tetraethylammonium on the maximum upstroke velocity in guinea-pig papillary muscles.
    Ban T; Kojima M; Ichiyama M; Sada H; Hamamoto T
    Arzneimittelforschung; 1989 Jul; 39(7):770-4. PubMed ID: 2551305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model study of time- and voltage-dependent effects of class I antiarrhythmic drugs in guinea-pig papillary muscles as related to external potassium concentration.
    Hamamoto T; Kojima M; Matsuzaki M; Kusukawa R; Ban T
    Arzneimittelforschung; 1994 Aug; 44(8):929-37. PubMed ID: 7945535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive inhibition of cardiac sodium channels by aprindine and lidocaine studied using a maximum upstroke velocity of action potential in guinea pig ventricular muscles.
    Kodama I; Toyama J; Yamada K
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1065-71. PubMed ID: 2439681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicorandil shortens action potential duration and antagonises the reduction of Vmax by lidocaine but not by disopyramide in guinea-pig papillary muscles.
    Kojima M; Ban T
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):203-12. PubMed ID: 2966899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Voltage-dependent effects of lidocaine and its metabolite, monoethylglycine xylidide (MEGX), on maximum rate of rise (Vmax) of action potential upstroke in guinea-pig papillary muscles].
    Hiraoka I; Oshita S; Itoh M; Sakabe T; Ban T
    Masui; 1991 Sep; 40(9):1394-9. PubMed ID: 1942514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 3,6-dimethylamino-dibenzopyriodonium edetate on action potentials in guinea pig papillary muscles.
    Ji GJ; Zhao DH; Liu DQ; Sheng BH
    Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):121-4. PubMed ID: 8352002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure activity studies of antiarrhythmic properties in a series of lidocaine and procainamide derivatives.
    Ehring GR; Moyer JW; Hondeghem LM
    J Pharmacol Exp Ther; 1988 Feb; 244(2):479-92. PubMed ID: 2450194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use-dependent effects of lidocaine in neonatal and adult ventricular myocardium.
    Jeck CD; Rosen MR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):738-43. PubMed ID: 2173756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tocainide and lidocaine on the transmembrane action potentials as related to external potassium and calcium concentrations in guinea-pig papillary muscles.
    Oshita S; Sada H; Kojima M; Ban T
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):67-82. PubMed ID: 6777703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of volatile anesthetics on conduction and maximum rate of rise of action potential upstroke in guinea-pig papillary muscles].
    Ozaki S
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):705-14. PubMed ID: 2606445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological and antiarrhythmic actions of tocainide in isolated heart preparations of the guinea pig.
    Borchard U; Hafner D; Ewerbeck S
    Arzneimittelforschung; 1985; 35(9):1367-74. PubMed ID: 3936506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of halothane and enflurane on conduction velocity and maximum rate of rise of action potential upstroke in guinea pig papillary muscles.
    Ozaki S; Nakaya H; Gotoh Y; Azuma M; Kemmotsu O; Kanno M
    Anesth Analg; 1989 Mar; 68(3):219-25. PubMed ID: 2919756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of action potential duration and resting potential on effects of quinidine, lidocaine and ethmozin on Vmax in guinea-pig papillary muscles.
    Jurevicius J; Muckus K; Macianskiene R; Chmel-Dunaj GN
    J Mol Cell Cardiol; 1991 Feb; 23 Suppl 1():103-14. PubMed ID: 2038070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 5-(N,N-hexamethylene)amiloride on action potentials, intracellular Na, and pH of guinea pig ventricular muscle in vitro.
    Lai ZF; Hotokebuchi N; Cragoe EJ; Nishi K
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):259-67. PubMed ID: 7511756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between selected sodium and potassium channel blockers in guinea pig papillary muscle.
    Wang L; Chiamvimonvat N; Duff HJ
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1056-62. PubMed ID: 8383735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency- and voltage-dependent effects of recainam on the upstroke velocity of action potential in rabbit ventricular muscle.
    Kamiya K; Takikawa R; Singh BN
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):630-7. PubMed ID: 2471002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tetraethylammonium on the action potential duration as modified by catecholamine-releasing action in guinea-pig papillary muscles.
    Kojima M; Ban T
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Sep; 334(1):29-36. PubMed ID: 3785438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidocaine blocks open and inactivated cardiac sodium channels.
    Matsubara T; Clarkson C; Hondeghem L
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Aug; 336(2):224-31. PubMed ID: 2446150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling of frequency-dependent effects of lignocaine homologues on the maximum upstroke velocity of action potentials in guinea-pig papillary muscles.
    Hamamoto T; Ichiyama M; Takahashi Y; Ban T
    Clin Exp Pharmacol Physiol; 1992 Jun; 19(6):457-68. PubMed ID: 1318810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupivacaine and lidocaine blockade of calcium-mediated slow action potentials in guinea pig ventricular muscle.
    Coyle DE; Sperelakis N
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1001-5. PubMed ID: 2443640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.